论文部分内容阅读
中商情报网:受市场发展较晚和医疗制度等影响,中国第三方医学检验行业尚处于发展初期,整体市场规模较小。目前中国从事第三方医学诊断市场规模不足20亿元,仅占医学诊断总收入的1%-2%。并且中国第三方医学诊断市场可检验的项目仅1000多项,而国外发达国家如美国可达4000多项,医学诊断水平差距明显特别是基因/分子诊断细分市场。
China Business Intelligence Network: Due to the late development of the market and the impact of the medical system, the third-party medical inspection industry in China is still in the early stages of its development with a small overall market. Currently, the scale of the third-party medical diagnostic market in China is less than 2 billion yuan, accounting for only 1% -2% of the total medical diagnosis. And there are only more than 1,000 items that can be tested in the third-party medical diagnostic market in China, while more than 4,000 items are available in developed countries such as the United States. The gap between the levels of medical diagnosis is particularly significant in the gene / molecular diagnostic market segment.